F.I.R.S.T™ screening platform

BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on expertise in immunology, cancer biology and antibody biology, it generates innovative immuno-oncology drug candidates using its proprietary F.I.R.S.T™ technology platform and n-CoDeR® antibody library. Its contract manufacturing unit, BioInvent Manufacturing, has produced drug substance for clinical trials since 1988.

Read more

antibody discovery and developmentclinical developmentGMP manufacturingn-CoDeR® antibody librarysingle use technology